Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids

Clinical trial NCT05123040 · TERMINATED

Trial details

NCT number: NCT05123040
Sponsor: Masonic Cancer Center, University of Minnesota
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute-graft-versus-host Disease

Start date: 2023-06-05
Primary completion: 2026-02-27
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.